Effect of Ranibizumab in Patients with Treatment-Naïve Retinopathy of Prematurity
Ranibizumab demonstrated effectiveness in initial disease regression but was linked to reactivation in all AROP and 60% of type 1 ROP cases, highlighting the importance of more frequent follow-ups after ranibizumab injection, particularly for AROP patients.
Authors
- Arooj Amjad
- Tayyaba Gul Malik (ORCID: https://orcid.org/0000-0003-1040-7114)
- HASSAN KHALID
- Iqra Khalid
- Shahid Muhammad
Institutions
- Lahore General Hospital (PK)
- Post Graduate Medical Institute (PK)
Publication Details
- Journal
- Turkish Journal of Ophthalmology
- Published
- 2025-08-21
- DOI
- https://doi.org/10.4274/tjo.galenos.2025.77992
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00